221 related articles for article (PubMed ID: 33371469)
21. Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer.
Zhao L; Ji G; Le X; Wang C; Xu L; Feng M; Zhang Y; Yang H; Xuan Y; Yang Y; Lei L; Yang Q; Lau WB; Lau B; Chen Y; Deng X; Yao S; Yi T; Zhao X; Wei Y; Zhou S
Cancer Res; 2017 Mar; 77(6):1369-1382. PubMed ID: 28087599
[TBL] [Abstract][Full Text] [Related]
22. FIH Is an Oxygen Sensor in Ovarian Cancer for G9a/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes.
Kang J; Shin SH; Yoon H; Huh J; Shin HW; Chun YS; Park JW
Cancer Res; 2018 Mar; 78(5):1184-1199. PubMed ID: 29259012
[TBL] [Abstract][Full Text] [Related]
23. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
Sawada K; Mitra AK; Radjabi AR; Bhaskar V; Kistner EO; Tretiakova M; Jagadeeswaran S; Montag A; Becker A; Kenny HA; Peter ME; Ramakrishnan V; Yamada SD; Lengyel E
Cancer Res; 2008 Apr; 68(7):2329-39. PubMed ID: 18381440
[TBL] [Abstract][Full Text] [Related]
24. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
Rynne-Vidal A; Au-Yeung CL; Jiménez-Heffernan JA; Pérez-Lozano ML; Cremades-Jimeno L; Bárcena C; Cristóbal-García I; Fernández-Chacón C; Yeung TL; Mok SC; Sandoval P; López-Cabrera M
J Pathol; 2017 Jun; 242(2):140-151. PubMed ID: 28247413
[TBL] [Abstract][Full Text] [Related]
25. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
26. Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer.
Nakamura H; Nagasaka K; Kawana K; Taguchi A; Uehara Y; Yoshida M; Sato M; Nishida H; Fujimoto A; Inoue T; Adachi K; Nagamatsu T; Arimoto T; Oda K; Osuga Y; Fujii T
BMC Cancer; 2016 Nov; 16(1):897. PubMed ID: 27855669
[TBL] [Abstract][Full Text] [Related]
27. Cancer-associated mesothelial cell-derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis.
Bajwa P; Kordylewicz K; Bilecz A; Lastra RR; Wroblewski K; Rinkevich Y; Lengyel E; Kenny HA
JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795484
[TBL] [Abstract][Full Text] [Related]
28. Ezrin Promotes the Proliferation, Migration, and Invasion of Ovarian Cancer Cells.
Li MJ; Xiong D; Huang H; Wen ZY
Biomed Environ Sci; 2021 Feb; 34(2):139-151. PubMed ID: 33685573
[TBL] [Abstract][Full Text] [Related]
29. SOX5 is involved in balanced MITF regulation in human melanoma cells.
Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R
BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636
[TBL] [Abstract][Full Text] [Related]
30. Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma.
Terauchi M; Kajiyama H; Yamashita M; Kato M; Tsukamoto H; Umezu T; Hosono S; Yamamoto E; Shibata K; Ino K; Nawa A; Nagasaka T; Kikkawa F
Clin Exp Metastasis; 2007; 24(5):329-39. PubMed ID: 17487558
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-inducible factor-1α induces CX3CR1 expression and promotes the epithelial to mesenchymal transition (EMT) in ovarian cancer cells.
Singh SK; Mishra MK; Singh R
J Ovarian Res; 2019 May; 12(1):42. PubMed ID: 31077234
[TBL] [Abstract][Full Text] [Related]
32. ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.
Li Y; Fei H; Lin Q; Liang F; You Y; Li M; Wu M; Qu Y; Li P; Yuan Y; Chen T; Jiang H
Oncogene; 2021 Aug; 40(32):5131-5141. PubMed ID: 34211089
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
[TBL] [Abstract][Full Text] [Related]
34. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of heat shock protein 27 correlates with peritoneal metastasis in epithelial ovarian cancer.
Zhao M; Shen F; Yin YX; Yang YY; Xiang DJ; Chen Q
Reprod Sci; 2012 Jul; 19(7):748-53. PubMed ID: 22534325
[TBL] [Abstract][Full Text] [Related]
36. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
[TBL] [Abstract][Full Text] [Related]
37. [The Importance of MITF Signaling Pathway in the Regulation of Proliferation and Invasiveness of Malignant Melanoma].
Urban P; Rabajdová M; Veliká B; Špaková I; Bolerázska B; Mareková M
Klin Onkol; 2016; 29(5):347-350. PubMed ID: 27739313
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple-negative breast cancer cells.
Zeng D; Liang YK; Xiao YS; Wei XL; Lin HY; Wu Y; Bai JW; Chen M; Zhang GJ
Int J Cancer; 2020 Jul; 147(2):490-504. PubMed ID: 32020593
[TBL] [Abstract][Full Text] [Related]
39. Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.
Torchiaro E; Lorenzato A; Olivero M; Valdembri D; Gagliardi PA; Gai M; Erriquez J; Serini G; Di Renzo MF
Oncotarget; 2016 Jan; 7(1):712-28. PubMed ID: 26625210
[TBL] [Abstract][Full Text] [Related]
40. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.
Zabouo G; Imbert AM; Jacquemier J; Finetti P; Moreau T; Esterni B; Birnbaum D; Bertucci F; Chabannon C
Breast Cancer Res; 2009; 11(1):R1. PubMed ID: 19123925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
